LH · 10-Q · 2026Q2 · Full report
Equity Method Losses
LABCORP HOLDINGS INC. · 2026-08-05 · Importance 59 · Surprise 82 · From source text
Second-quarter equity method loss increased to $6.2 million from $1.7 million, a 259.6% year-over-year increase. Six-month equity method loss rose to $11.3 million from $2.0 million, a 475.0% increase. The losses represent Labcorp’s ownership share in joint ventures and equity investments in healthcare companies. The increase was primarily caused by losses recognized from the SYNLAB investment.
Key facts
- Equity method loss, net for the three months ended June 30, 2026, was $(6.2) compared to $(1.7) in the corresponding period in 2025, an increase of 259.6%. source
- Equity method loss, net for the six months ended June 30, 2026, was $(11.3) compared to $(2.0) in the corresponding period in 2025, an increase of 475.0%. source
- The increase in equity method loss, net for the three months ended June 30, 2026, was primarily due to the loss recognized from the SYNLAB investment. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | realized | -0.3% | Equity method loss, net for the six months ended June 30, 2026, was $(11.3) compared to $(2.0) in the corresponding period in 2025, an… |
| net_income | negative | realized | -0.1% | Equity method loss, net for the three months ended June 30, 2026, was $(6.2) compared to $(1.7) in the corresponding period in 2025, an… |